Response to Pegylated Interferon in a COVID-19 Positive Male
with Metastatic Jejunal Neuroendocrine Tumor Treated with Everolimus
Arthur E. Frankel, MD1*; Wai C.
Yip1; Eknath Naik, MD, PhD1; Hans C.
Hasselbalch, MD, PhD2.
1Department of Medicine, West Palm Beach VA Medical
Center, West Palm Beach, FL; 2Department of
Hematology, Zealand University Hospital, Roskilde, Denmark.
*Correspondence to: Arthur E. Frankel, MD, Bldg 15 BA42, West Palm Beach
VA Medical Center, West Palm Beach, FL 33410; telephone: 254-718-0781;
email:
afrankel59@gmail.com.
The study was conducted in accordance with the Declaration of Helsinki.
Informed consent was obtained for the interferon therapy and case
report.
Abstract word number 89; Text word count 3690; Tables 1.
Conflicts of interest: None